Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

202
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
202
Tonsillitis II: Management01:26

Tonsillitis II: Management

409
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
409
Management of Insomnia01:19

Management of Insomnia

558
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
558
Managing Impressions01:19

Managing Impressions

164
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
164
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

485
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
485
Angina IV: Management01:26

Angina IV: Management

249
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
249

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraperitoneal versus transperitoneal robot-assisted laparoscopic total prostatectomy: comparison after propensity score matching.

The French journal of urology·2026
Same author

Real-word evidence in anti-VEGF naive patients treated with pazopanib for metastatic renal cell carcinoma (mRCC), the APOLON Study.

ESMO real world data and digital oncology·2026
Same author

Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study.

ESMO open·2024
Same author

Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study.

European journal of cancer (Oxford, England : 1990)·2024
Same authorSame journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Surgical complications and graft survival in kidney transplant recipients according to CT-scans evaluation.

The French journal of urology·2023

Related Experiment Video

Updated: Jan 22, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K

[Oligometastatic prostate cancer management].

F Kleinclauss1, A Thiery-Vuillemin2

  • 1Service d'urologie, andrologie et transplantation rénale, CHRU Besançon, Besançon, France; Université de Franche-Comté, Besançon, France; INSERM 1098, Besançon, France.

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|July 17, 2019
PubMed
Summary

Oligometastatic prostate cancer, characterized by limited metastases, is increasingly detected with advanced imaging. Management requires individualized patient care due to a lack of definitive guidelines.

Keywords:
CancerMetastaseMétastaseOligo-metastaseOligo-métastaseProstate

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.8K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

Related Experiment Videos

Last Updated: Jan 22, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.8K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

Area of Science:

  • Oncology
  • Urology

Background:

  • Oligometastatic prostate cancer is a distinct clinical entity defined by a limited number of metastases.
  • Increased detection is linked to advancements in imaging technologies like PET scans using Choline or PSMA.
  • This state can manifest at initial diagnosis (de novo) or upon recurrence after primary treatment.

Purpose of the Study:

  • To review the current understanding of the biology and management strategies for oligometastatic prostate cancer.
  • To highlight the challenges posed by the lack of a standardized definition and treatment guidelines.

Main Methods:

  • A comprehensive literature search was conducted using Medline, Embase, and clinicaltrials.gov.
  • Keywords included "prostate cancer," "metastasis," and "oligo-metastasis."
  • Ninety-nine relevant publications were selected for review based on methodology, language, and relevance.

Main Results:

  • There is no universal consensus on the definition of oligometastatic prostate cancer, with variations in the number and location of metastases reported.
  • Evidence-based data and treatment guidelines are scarce.
  • Preliminary findings suggest that treating the primary tumor with androgen deprivation therapy may improve survival in de novo cases, while metastasis-directed therapy is used for recurrent disease, though further analysis is needed.

Conclusions:

  • Management of oligometastatic prostate cancer necessitates a personalized approach.
  • Treatment decisions should integrate primary tumor characteristics, metastatic burden, and individual patient factors.
  • Further prospective clinical trials are crucial to establish evidence-based guidelines.